Gilder Gagnon Howe & Co’s Hinge Health HNGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.8M Sell
142,024
-8,525
-6% -$463K 0.12% 123
2026
Q1
$5.81M Sell
150,549
-51,663
-26% -$2.15M 0.07% 141
2025
Q4
$9.39M Sell
202,212
-3,095
-2% -$149K 0.1% 118
2025
Q3
$10.1M Buy
205,307
+19,458
+10% +$1.02M 0.1% 117
2025
Q2
$9.62M Buy
+185,849
New +$7.51M 0.1% 114

Other funds holding HNGE

Gilder Gagnon Howe & Co's HNGE Position: Q2 2026 in Review

Gilder Gagnon Howe & Co reduced its Hinge Health (HNGE) stake by 5.7% in Q2 2026, selling an estimated $463K and leaving 142,024 shares worth $11.8M. The position accounts for 0.12% of the portfolio, ranked #123.

Gilder Gagnon Howe & Co first reported a position in HNGE in Q2 2025 and has held it in 5 quarters since. 276 funds tracked by Wall St. Rank hold HNGE as of Q2 2026.

  • Gilder Gagnon Howe & Co held 142,024 shares of Hinge Health worth $11.8M as of Q2 2026.
  • Gilder Gagnon Howe & Co sold 8,525 Hinge Health shares in Q2 2026, an estimated $463K.
  • Hinge Health made up 0.12% of Gilder Gagnon Howe & Co's portfolio in Q2 2026, its #123 holding.
  • Gilder Gagnon Howe & Co first reported a position in Hinge Health in Q2 2025 and has held it in 5 quarters since.
  • 276 funds tracked by Wall St. Rank held Hinge Health as of Q2 2026.

Based on Gilder Gagnon Howe & Co's 13F filing for Q2 2026, filed 14 Aug 2026.